Work

Are we any WISER yet? Progress and contemporary need for smart trials to include women in coronary artery disease trials

Year: 2022

Type: review

Source: Contemporary Clinical Trials

DOI: 10.1016/j.cct.2022.106762

Authors: Ana Iribarren, Márcio Augusto Diniz, C. Noel Bairey Merz, Chrisandra Shufelt, Janet Wei

Institutions: Cedars-Sinai Medical Center, Cedars-Sinai Smidt Heart Institute

Language: English

Topic: Sex and Gender in Healthcare

Subfield: Public Health, Environmental and Occupational Health

Field: Medicine

Domain: Health Sciences

SDGs: Good health and well-being, Reduced inequalities, Gender equality

Open Access status: green

Funders: Cedars-Sinai Medical Center, National Institutes of Health, National Institute on Aging, National Heart, Lung, and Blood Institute

Awards: Women's Ischemia Syndrome Evaluation (WISE) - Mechanisms of Coronary Microvascular Dysfunction Leading to Pre-Heart Failure with Preserved Ejection Fraction (HFpEF), CIAO-ISCHEMIA - Resubmission - 1, Whole-Heart Myocardial Blood Flow Quantification Using MRI, The Microvascular Aging and Eicosanoids - Women's Evaluation of Systemic Aging Tenacity (MAE-WEST) ("You are never too old to become younger!") Specialized Center for Research Excellence (SCORE), Myocardial Steatosis in Women with Coronary Microvascular Dysfunction: Defining the Pathway to Heart Failure with Preserved Ejection Fraction (HFpEF)

OpenAlex ID: W4224285072

FWCI: 0.67

Cites: 138

Cited by: 17

Related to: 10